Form 8-K - Current report:
SEC Accession No. 0000950170-24-091766
Filing Date
2024-08-06
Accepted
2024-08-06 16:05:13
Documents
12
Period of Report
2024-08-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K fgen-20240806.htm   iXBRL 8-K 40850
2 EX-99.1 fgen-ex99_1.htm EX-99.1 237354
  Complete submission text file 0000950170-24-091766.txt   403497

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT fgen-20240806.xsd EX-101.SCH 23887
14 EXTRACTED XBRL INSTANCE DOCUMENT fgen-20240806_htm.xml XML 4509
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Filer) CIK: 0000921299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36740 | Film No.: 241179096
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)